A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group. (Q51999001)
Jump to navigation
Jump to search
scientific article published in September 1997
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group. |
scientific article published in September 1997 |
Statements
1 reference
A 12-month, randomized, placebo-controlled trial of propentofylline (HWA 285) in patients with dementia according to DSM III-R. The European Propentofylline Study Group. (English)
1 reference
J Marcusson
1 reference
M Rother
1 reference
B Kittner
1 reference
M Rössner
1 reference
R J Smith
1 reference
T Babic
1 reference
V Folnegovic-Smalc
1 reference
H J Möller
1 reference
K H Labs
1 reference
1 September 1997
1 reference
8
1 reference
5
1 reference
320-328
1 reference
Identifiers
1 reference
1 reference